MetaCap

Who Owns Helus Pharma Stock?

NASDAQ: HELPHealth CareBiotechnology: Pharmaceutical PreparationsUSD

6.11-0.67 (-9.88%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
39.00%
Institutional holders
124
  • Institutions 39.0%
  • Insiders 13.2%
  • Public and other 47.8%

Who owns Helus Pharma stock?

Institutional investors own about 39.0% of Helus Pharma's shares, spread across 124 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 13.20% of HELP.

The largest institutional holders are Venrock Adviser, LLC (4.83%), Orbimed Advisors LLC. (4.10%) and Adage Capital Partners GP L.L.C. (3.83%). Together, the top 10 institutions control 26.6% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their HELP positions and 2 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of HELP

Helus Pharma top institutional holders
InstitutionShares% HeldChange
Venrock Adviser, LLC3.85M4.83%0.0%
Orbimed Advisors LLC.3.27M4.10%-14.7%
Adage Capital Partners GP L.L.C.3.06M3.83%+337.1%
Millennium Management Llc2.63M3.30%+8.9%
Rosalind Advisors, Inc.1.96M2.45%+27.7%
Sphera Funds Management Ltd.1.62M2.03%+64.2%
Acorn Capital Advisors, LLC 1.54M1.93%0.0%
Sio Capital Management, LLC1.30M1.63%+100.0%
DCF Advisers, LLC1.00M1.26%-30.1%
Nan Fung Group Holdings Limited987.22K1.24%+114.6%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of HELP

Helus Pharma top fund holders
FundShares% Held
AdvisorShares Trust-AdvisorShares Psychedelics ETF360.15K0.45%
ROYCE FUND-Royce Smaller-Companies Growth Fund232.00K0.29%
Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund45.15K0.06%
Fidelity Commonwealth Trust-Fidelity Nasdaq Composite Index ETF30.83K0.04%
SPDR INDEX SHARES Fd.S-State Street SPDR S&P Intl Small Cap ETF29.50K0.04%
Invesco Exch-Trd Fd. TRT II-Invesco NASDAQ Future Gen 200 ETF10.20K0.01%
TIFF INVESTMENT PROGRAM-TIFF Multi-Asset Fund1.80K0.00%

Frequently asked questions

Who is the largest shareholder of Helus Pharma?

Venrock Adviser, LLC is the largest institutional shareholder of HELP, owning 4.83% of shares outstanding (3.85M shares) as of its latest 13F filing.

What percentage of Helus Pharma is owned by institutions?

Institutions own about 39.0% of HELP shares and 44.9% of the public float.

How much of Helus Pharma do insiders own?

Insiders, such as officers and directors, own about 13.20% of HELP shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related